XEMC:CA:TSX-iShares MSCI Emerging Markets ex China Index ETF (CAD)

ETF | Others |

Last Closing

CAD 49.68

Change

+0.49 (+1.00)%

Market Cap

N/A

Volume

302.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.20 (+0.70%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.31B
PHYS-U:CA Sprott Physical Gold Trust

+0.24 (+1.18%)

CAD 4.76B
XEQT:CA iShares Core Equity Portfolio

-0.07 (-0.22%)

CAD 4.70B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.06 (+0.17%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.89 (+3.68%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.01 (-0.04%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 2.53B

ETFs Containing XEMC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.81% 66% D+ 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.81% 65% D 54% F
Trailing 12 Months  
Capital Gain 24.39% 70% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.39% 68% D+ 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.02% 75% C 59% D-
Dividend Return 6.02% 75% C 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.92% 52% F 77% C+
Risk Adjusted Return 76.05% 92% A 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike